Mohammad Mahbubul Karim

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

Sabeena Ahmed, Mohammad Mahbubul Karim, Allen G. Ross et al. · International Journal of Infectious Diseases · 2020 · 296 citations · Full text

Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach

Huong T L Vu, Chuc T K Nguyen, Sureeporn Punpuing et al. · The Lancet Global Health · 2021 · 263 citations · Full text

Single-Dose Azithromycin for the Treatment of Cholera in Adults

Debasish Saha, Mohammad Mahbubul Karim, Wasif Ali Khan et al. · New England Journal of Medicine · 2006 · 174 citations

CRYPTOSPORIDIOSIS AMONG BANGLADESHI CHILDREN WITH DIARRHEA: A PROSPECTIVE, MATCHED, CASE-CONTROL STUDY OF CLINICAL FEATURES, EPIDEMIOLOGY AND SYSTEMIC ANTIBODY RESPONSES

Wasif A. Khan, Kathleen A. Rogers, Mohammad Mahbubul Karim et al. · American Journal of Tropical Medicine and Hygiene · 2004 · 65 citations · Full text

Susceptible Host, Clinical Infectious Disease, Clinical Epidemiology +14

Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial

Debasish Saha, Wasif Ali Khan, Mohammad Mahbubul Karim et al. · The Lancet · 2005 · 55 citations

12-Dose Erythromycin, Antimicrobial Stewardship, Antibiotics +10